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ABSTRACT 
 
Objective:  Vaccination is considered very important for proper health and development of child. It helps in keeping 
a child disease free. Although most of the developing countries are considered polio free, Pakistan is not one of 
them. The study is designed to evaluate whether storage conditions and stability effect polio vaccine leading to its 
inefficacy. Methodology: It is a cross sectional survey based study consisting of N=200 (both males and females) 
age group 20-55 years from medical field and polio workers. The study was conducted for 2 month. Data was 
collected from the participants by directly contacting with them and the answers were recorded as open ended. 
Results and discussion: From our study we came to know that 87% of population was aware about polio vaccine, 
55% was aware that it is stored in cool place but 41% had no idea that at what temperature it is stored. 67% 
population thought its efficacy is maintained if kept in ice box for prolonged time. Conclusion: From our study we 
came to conclude that polio vaccine should be stored at standard temperature in refrigerators, not kept in ice boxes 
for prolonged time.  Awareness should be created regarding this and it would be better option to dispense it from 
Community Pharmacy to avoid stability issues. 
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Introduction 
 
 
Poliovirus (PV), an enterovirus belonging to the 
Picornaviridae family is the etiological agent of 
poliomyelitis, an acute paralytic disease. [1] It is a 
small RNA virus, just 30 nm across and with a 
complete genome of only approximately 7500 
nucleotides. [2] It is shed in enormous quantities in the 
throat and intestines of infected individuals such that a 
gram of stool can contain several million virus 
particles[2] This disease results from lower motor 
neuron damage and is characterized by asymmetric 
persisting weakness (flaccid paralysis). [1] 
Poliomyelitis is caused by any one of the three 
serotypes of poliovirus (type 1, type 2 or type 3) that 
can be prevented through vaccination. [3]Poliomyelitis 
disease may attack nerve cells of the brain and spinal 
 _______________________________ 
*Correspondence  
Sana Sarfaraz 
Faculty of Pharmacy, Jinnah University for women 
Karachi, Pakistan. 
E Mail: sana.sarfraz@live.com 
 
 
cord. Symptoms include fever, headache, sore throat, 
and vomiting. Some victims develop neurological 
complications, including stiffness of the neck and back, 
weak muscles, pain in the joints, and paralysis of one 
or more limbs or respiratory muscles. In severe cases it 
may be fatal, due to respiratory paralysis. [4]The 
propagation of the PV in vitro led to the development 
of the vaccines against poliomyelitis: the formalin-
inactivated vaccine (IPV) by Jonas Salk (1953) and the 
live-attenuated vaccines (OPV) by Albert Sabin (1956). 
[5]Immunization is the most precious gift that a health 
care worker can give a child [6] Vaccination is a 
crucial tool for preventing and controlling disease, but 
its use has been plagued by controversies worldwide 
[7-12] Vaccines are sensitive biological substances that 
gradually lose their potency with time [13] and this loss 
of potency can be accelerated when stored out of the 
recommended range of temperature [13, 14, 15] Any 
loss of potency in a vaccine is permanent and 
irreversible. Consequently, a proper storage of vaccines 
at the recommended temperature conditions is vital so 
that vaccine’s potency is retained up to the moment of 
administration [13].Timely vaccination is important to 
obtain adequate disease protection. [16-19]The first 
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vaccination is at birth where the BCG  [Bacillus 
Calmette–Guérin] (birth to 8 weeks) and oral polio 
(birth to 4 weeks) vaccines are given. The first dose is 
given at 6 weeks (4 weeks to 2 months), then again at 
10 weeks (8 weeks to 4 months), and at 14 weeks (12 
weeks to 6 months).). [20] Two vaccines, live 
attenuated oral poliovirus vaccine (OPV) and 
inactivated poliovirus vaccine (IPV) are used 
throughout the world to protect against polio. [21]OPV 
is used instead of IPV for several reasons. [21] OPV is 
more cost effective than IPV [22]; primary 
immunization with OPV induces superior intestinal 
immunity than IPV.OPV thus has the potential to better 
prevent transmission of wild viruses; OPV confers 
contact immunity through passive immunization of 
unvaccinated persons from viruses shed by vaccines. 
OPV is administered in oral drops, which are easy to 
store and transport. The United States Center for 
Disease Control recommends polio vaccination 
boosters for travelers and those who live in countries 
where the disease is occurring.[23] Once infected there 
is no specific treatment. The objective of the study is to 
evaluate awareness regarding storage conditions of 
polio vaccine whether stability of polio vaccine is 
effected due to improper storage leading to inefficacy 
of  polio vaccine which might be one of the possible 
reasons polio is still not eradicated from Pakistan and 
what measures can be adopted for proper storage and 
dispensing.  
 
Materials and method 
 It is a cross sectional survey based study comprising of 
N= 200 individuals. The study was carried out in 
various public and private sector hospitals of Karachi 
and Retail Drug seller stores. The sample population 
consisted of Physicians, Nurses, Drug Sellers and polio 
workers. The data was collected by directly contacting 
with persons and the answers were recorded as open 
ended. 
Sample selection 
Inclusion Criteria 
o Must be registered physicians from 
PMDC 
o Must be registered Nurse from PNC 
o Must be working in any public and 
private sector tertiary care hospital of 
Karachi  
o Must be authentic Polio worker 
o Must be able to speak and understand 
local language Urdu and English 
Exclusion Criteria 
Interns and trainees 
Ethical consideration 
The participation of every healthcare practitioner was 
voluntarily. All the participants had complete right to 
withdraw from study without any prior notice. 
Results and discussion 
 The data was analyzed by SPSS version 19 and by 
using Binomial testing and Chi square test the results 
were evaluated. P value of 0.05 (5%) or less was 
considered statistically significant. The results have 
been presented as follows: 
Table 1: Binomial Test 
 
 Categor
y 
N Observed 
Prop. 
Test 
Prop. 
Exact Sig. 
(2-tailed) 
Awareness regarding 
Polio Vaccine 
 
 
Group 
1 
No 26 .13 .50 .000 
 
Group 
2 
yes 174 .87   
 
    
Total  200 1.00   
Awareness regarding 
storage of polio 
vaccine 
 
 
Group 
1 
yes 110 .55 .50 .179 
 
Group 
2 
no 90 .45   
 
Total  200 1.00   
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Stable in ice box for 
prolonged time 
 
 
Group 
1 
yes 106 .53 .50 .437 
 
Group 
2 
no 94 .47   
 
Total  200 1.00   
Awareness regarding 
community Pharmacy 
 
 
Group 
1 
yes 76 .38 .50 .001 
 
Group 
2 
no 124 .62   
 
Total  200 1.00   
Community pharmacy 
better 
option for dispensing 
polio vaccine 
 
 
Group 
1 
yes 24 .12 .50 .000 
 
Group 
2 
no 176 .88   
 
Total  200 1.00   
 
 
 
Table 2: Chi-Square Test 
 
 Awareness  
regarding 
Polio 
Vaccine type 
Awareness 
regarding 
temperature 
Efficacy 
maintained 
in ice box 
Chi-Square 195.040 71.160 130.690 
df 3 3 2 
Asymp. Sig. .000 .000 .000 
 
 
Graph 1: Awareness regarding Polio Vaccine 
 
Graph 2: Awareness regarding storage of Oral Polio Vaccine 
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Graph 3:  Oral Polio Vaccines Efficacy and Stability in Ice box for prolonged period 
 
 
Graph 4: Awareness Regarding Community Pharmacy and it being a better option for Dispensing Polio 
Vaccine 
55%
45%
37%
16%
6%
41%
0
20
40
60
80
100
120
yes no -25 -35 -43 No idea
P
e
rc
e
n
t 
o
f 
P
o
p
u
la
ti
o
n
Storage Temperature
yes
no
-25
-35
-43
No idea
53%
47%
67%
33%
0
20
40
60
80
100
120
140
160
P
e
rc
e
n
t 
o
f 
P
o
p
u
la
ti
o
n
stable
Not Stable
Efficacy Maintained
Efficacy Compromised
 Asian Pac. J. Health Sci., 2015; 2(4): 20-26                                           e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Sarfaraz et al                  ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2015; 2(4): 20-26 
www.apjhs.com      24 
 
 
Table 1 shows that awareness regarding polio vaccine 
was highly significant i.e p<0.000 however results 
regarding storage conditions of polio vaccine and 
stability for prolonged periods in ice box were 
insignificant. The results showed awareness regarding 
community pharmacy was moderately significant as 
majority of people were not aware about it p<0.001 
where as dispensing of polio vaccine from community 
pharmacy also had highly significant results i.e 
p<0.000 majority of people did not agree about 
importance of community pharmacy in dispensing 
polio vaccine.Table 2 shows that when chi-square was 
applied we found that highly significant population was 
unaware of the temperature at which polio is stored, 
about whether it is live or dead vaccine and regarding 
effect on efficacy if it it kept in ice box for prolonged 
time period i.e p in all situations was P<0.000 
Graph 1 shows Awareness regarding Polio Vaccine. 
Our results show that majority (87%) of the population 
is aware about Polio Vaccines and only a minority 
(13%) is unaware about it.  It also shows that   54% of 
population considered Polio vaccine as a live vaccine 
while only a minority considered it dead. 18% 
population knew that Polio vaccine is both Live and 
Dead vaccine. Since the 1950s there have been two 
safe and effective vaccines against poliomyelitis: 
Inactivated (killed) polio vaccine – known as IPV or 
Salk – which is made from wild strains and 
administered by injection; live attenuated (weakened) 
oral polio vaccine – OPV or Sabin – which is given by 
mouth. [24 ]OPV has been used in the Global Polio 
Eradication Initiative to reduce polio cases by more 
than 99% and to restrict poliovirus circulation to a 
handful of countries.  
Graph 2 shows Awareness regarding storage of Oral 
Polio Vaccines. Our results show that 55% of the 
population is aware about the storage of Oral Polio 
Vaccines while 45% is unaware about it.  It also shows 
that  majority of the population had no idea about the 
storage temperature at which polio vaccine should be 
maintained while 37% thought that it is stored at -25 ͦC. 
According to World Health Organization (WHO) 
recommendations OPV must be kept frozen between -
15oC and -25oC. [25 ]Proper vaccine storage and 
handling practices play a very important role in 
protecting individuals and communities from vaccine-
preventable diseases. [6 ] 
 
Graph 3 shows Oral polio Vaccine Efficacy and 
Stability in Ice box for prolonged period. Our results 
show that majority of the population believed that the 
Polio Vaccine remain stable when kept in ice box for 
prolong period of time. It also shows that 67% of 
population thought that the efficacy was maintained 
when placed in ice box for prolonged period of time 
only 47% of the population had an idea that vaccine 
does not remain stable when kept in ice box for 
prolonged time period and 33% thought that efficacy 
gets compromised if kept for prolonged periods in 
icebox. WHO recommendation states thatOPV should 
not be kept atrefrigerator temperatures (0C to 8C) at 
health centres for more than one month, nor transported 
at these temperatures for more than one week. [26] The 
system used for keeping and distributing vaccines in 
good condition is called the “cold chain.” This consists 
of a series of storage and transport links, all of which 
are designed to keep the vaccine at the correct 
temperature until it reaches the recipient. [27] 
Researchers reported defects in the cold chain and the 
need to strengthen this mechanism to achieve 
successful polio eradication.[28] Use of magnesium 
chloride as preservative would help to increase the 
stability of OPV and to minimize reliance on the cold 
chain system [29]  
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Graph 4 shows Awareness regarding Community 
Pharmacy and it being a better option for Dispensing 
Polio Vaccine. Our results show that majority of the 
population is unaware about Community Pharmacy and 
did not think it could play a role in correct dispensing 
of polio vaccine. Community pharmacy in the UK is 
established as a very well known pharmacy profession. 
[30] Buying medicine from a community pharmacy 
would be very beneficial for people as they would be 
correctly councelled about its use too. 
 
Conclusion 
From our study we came to conclude that there is a 
need to create awareness in Health care professional 
and Polio workers regarding storage of oral polio 
vaccine as loss in its stability could be one of the 
causes of its inefficacy. A better option would be to 
dispense it from a community pharmacy so that proper 
supervision would be carried out during dispensing. 
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